ConductScience.org, home

Paper41596328

Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line.

Samaszko-Fiertek J and 2 others. Int J Mol Sci, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line. Papers, record 41596328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596328

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Samaszko-Fiertek JJustynahttps://orcid.org/0000-0003-0629-9579
2Dmochowska BBarbarahttps://orcid.org/0000-0002-7760-8482
3Madaj JJanuszhttps://orcid.org/0000-0002-8775-8951

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Breast NeoplasmsMajor topic
Coordination ComplexesMajor topic
Humans
Schiff Bases
Female
MCF-7 Cells
Ligands

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DS/531-T100-D501-25University of GdańskPubMed

Source PubMed

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136823294Novel Bromo and methoxy substituted Schiff base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, and ADMET studies.Sci Rep2023https://conductscience.org/library/papers/36823294PubMed
235164049Different Schiff Bases-Structure, Importance and Classification.Molecules2022https://conductscience.org/library/papers/35164049PubMed
339502428Design and synthesis of a novel isoleucine-derived Schiff base ligand: Structural characterization, molecular docking, and in vitro biological activity evaluation.Int J Health Sci (Qassim)2024https://conductscience.org/library/papers/39502428PubMed
433634805Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.Dalton Trans2021https://conductscience.org/library/papers/33634805PubMed
534139626A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases.Eur J Med Chem2021https://conductscience.org/library/papers/34139626PubMed
637446670Synthesis, Crystal Structure, Antibacterial and In Vitro Anticancer Activity of Novel Macroacyclic Schiff Bases and Their Cu (II) Complexes Derived from S-Methyl and S-Benzyl Dithiocarbazate.Molecules2023https://conductscience.org/library/papers/37446670PubMed
737077261Synthesis, DNA binding and biological evaluation of benzimidazole Schiff base ligands and their metal(ii) complexes.RSC Adv2023https://conductscience.org/library/papers/37077261PubMed
824403503Understanding and improving platinum anticancer drugs--phenanthriplatin.Anticancer Res2014https://conductscience.org/library/papers/24403503PubMed
935456624Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections.Pharmaceutics2022https://conductscience.org/library/papers/35456624PubMed
1036183642Synthesis, characterization, antioxidant potential, and cytotoxicity screening of new Cu(II) complexes with 4-(arylchalcogenyl)-1H-pyrazoles ligands.J Inorg Biochem2022https://conductscience.org/library/papers/36183642PubMed
1139420621A novel copper(II) complex with a salicylidene carbohydrazide ligand that promotes oxidative stress and apoptosis in triple negative breast cancer cells.Dalton Trans2024https://conductscience.org/library/papers/39420621PubMed
1237049692Catalytic, Theoretical, and Biological Investigations of Ternary Metal (II) Complexes Derived from L-Valine-Based Schiff Bases and Heterocyclic Bases.Molecules2023https://conductscience.org/library/papers/37049692PubMed
1338922505
Novel tetraaza macrocyclic Schiff base complexes of bivalent zinc: microwave-assisted green synthesis, spectroscopic characterization, density functional theory calculations, molecular docking studies, in vitro antimicrobial and anticancer activities.
Biometals2024https://conductscience.org/library/papers/38922505PubMed
1440054814Exploring the enzyme inhibitor potential and therapeutic applications of transition metal complexes of Methoxy-Schiff Base via triangular investigation.Int J Biol Macromol2025https://conductscience.org/library/papers/40054814PubMed
1537959772Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes.Molecules2023https://conductscience.org/library/papers/37959772PubMed
1638065049Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity.J Inorg Biochem2024https://conductscience.org/library/papers/38065049PubMed
1737129705A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imaging.J Biol Inorg Chem2023https://conductscience.org/library/papers/37129705PubMed
1830108933Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.Medchemcomm2018https://conductscience.org/library/papers/30108933PubMed
1924102434Advances in copper complexes as anticancer agents.Chem Rev2014https://conductscience.org/library/papers/24102434PubMed
2038599004Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer.J Inorg Biochem2024https://conductscience.org/library/papers/38599004PubMed

See all 61 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42076047Palladium(II) Complexes with Chloro-Substituted Salicyl Schiff Bases: Exploring Multimodal Anticancer Mechanisms and Catalase Inhibition.Molecules2026https://conductscience.org/library/papers/42076047

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41596328

GET https://conductscience.org/api/papers/v1/41596328/references?page=2